Porton Pharma Solutions Ltd.

300363

CNE100001S57

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-06-13 EDT			5-day change	1st Jan Change
13.17 ^CNY	-2.95%		-2.95%	-47.63%

05-23	Porton Pharma Solutions Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024	CI
04-26	Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Porton Pharma Solutions Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024

May 22, 2024

Porton Pharma Solutions Ltd. announced final cash dividend/10 shares (tax included) of CNY 4.87000000 on A shares for the year 2023. Record date: 28 May 2024. Ex-date: 29 May 2024.

Payment date: 29 May 2024.

Latest news about Porton Pharma Solutions Ltd.

Porton Pharma Solutions Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024	05-22	CI
Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
Porton Pharma Solutions Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-26	CI
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.	04-09	CI
Porton Pharma Solutions Ltd.'s Equity Buyback announced on October 28, 2023, has closed with 1,260,000 shares, representing 0.23% for CNY 29.87 million.	04-08	CI
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.	04-03	CI
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.	01-03	CI
Porton Pharma Solutions Ltd. announces an Equity Buyback for CNY 30 million worth of its shares.	23-10-27	CI
Porton Pharma Solutions Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Porton Pharma Solutions Ltd. authorizes a Buyback Plan.	23-10-26	CI
Porton Pharma Solutions Ltd. agreed to acquire 30% stake in Hubei Yuyang Pharmaceutical Co., Ltd. for CNY73.5 million.	23-09-14	CI
Porton Pharma Solutions Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-18	CI
Porton Pharma Solutions Ltd. Announces Final Dividend for the Year 2022, Payable on 09 May 2023	23-04-28	CI
Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-21	CI
Porton Pharma Solutions Ltd. Approves Cash Dividend for the Year 2022	23-04-18	CI
Porton Pharma Sees Up to 25% Profit Drop in Q1 on Lower Orders	23-04-03	MT
Porton Pharma Solutions Ltd. Proposes Profit Distribution for 2022	23-03-27	CI
Porton Pharma Solutions Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-24	CI
Porton Pharma to Build 2.5 Billion Yuan Drug R&D, Production Facility	23-01-20	MT
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on August 4, 2022.	22-11-22	CI
Porton Pharma Solutions Ltd.'s Equity Buyback announced on August 4, 2022, has closed with 2,022,344 shares, representing 0.37% for CNY 100 million.	22-11-20	CI
Shanghai Feiteng Pharmaceutical Technology Co., Ltd. announced that it has received CNY 60 million in funding from Porton Pharma Solutions Ltd.	22-10-26	CI
Porton Pharma Solutions Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on August 4, 2022.	22-10-10	CI
Porton Pharma Solutions Ltd.(XSEC:300363) added to S&P Global BMI Index	22-09-19	CI

Chart Porton Pharma Solutions Ltd.

Duration

Period

More charts

Porton Pharma Solutions Ltd., formerly Porton Fine Chemicals Ltd., is a China-based company principally engaged in the provision of customized pharmaceutical research and production services. The Company is also engaged in the multi-client product manufacturing businesses and pharmaceutical and chemical commerce businesses. The products of the Company include anti-viral, anti-diabetic, hypolipidemic, anti-cancer, anesthesia analgesia and anti-bacterial pharmaceuticals, among others. The Company operates its businesses in Europe, North America, Asia and China, among others.

Sector

Pharmaceuticals

Calendar

2024-08-18 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Porton Pharma Solutions Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

13.17 CNY

Average target price

26.65 CNY

Spread / Average Target

+102.35%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
PORTON PHARMA SOLUTIONS LTD.	-47.63%	991M
NOVO NORDISK A/S	+41.96%	630B
JOHNSON & JOHNSON	-7.15%	350B
MERCK & CO., INC.	+18.77%	328B
ABBVIE INC.	+8.79%	298B
ASTRAZENECA PLC	+18.02%	246B
ROCHE HOLDING AG	+1.27%	225B
NOVARTIS AG	+11.95%	218B
AMGEN INC.	+3.68%	160B
PFIZER, INC.	-4.38%	156B

Other Pharmaceuticals